Insulet Corporation(PODD)Earnings, Financials & Key Ratios

PODD•NASDAQ

$151.17

$10.61B mkt cap·43.4× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryDiabetes care and insulin delivery

AboutInsulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.Show more

Revenue$2.71B+30.7%
EBITDA$587M+50.6%
Net Income$247M-40.9%
EPS (Diluted)3.48-39.8%
Gross Margin71.63%+2.6%
EBITDA Margin21.67%+15.2%
Operating Margin17.5%+17.3%
Net Margin9.12%-54.8%
ROE18.12%-57.9%
ROIC20.13%+39.5%
Debt/Equity0.69-40.9%
Interest Coverage5.94-26.0%

Analysis→Technical→

PODD Key Insights

Insulet Corporation (PODD) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 31.8%
✓Strong 5Y profit CAGR of 105.2%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 24.5%
✓Share count reduced 2.7% through buybacks

✗Weaknesses

✗Weak momentum: RS Rating 8 (bottom 8%)
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PODD Price & Volume

Insulet Corporation (PODD) stock price & volume — 10-year historical chart

Loading chart...

PODD Growth Metrics

Insulet Corporation (PODD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years26.22%

5 Years24.53%

3 Years27.54%

TTM31.93%

Profit CAGR

10 Years-

5 Years105.15%

3 Years277.32%

TTM-24.71%

EPS CAGR

10 Years-

5 Years103.38%

3 Years275.36%

TTM-22.66%

Return on Capital

10 Years6.02%

5 Years10.41%

3 Years14.26%

Last Year18.69%

PODD Recent Earnings

Insulet Corporation (PODD) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)

Q2 2026Latest

May 6, 2026

EPS

$1.42

Est $1.19

+19.3%

Revenue

$762M

Est $730M

+4.4%

Q1 2026

Feb 18, 2026

EPS

$1.55

Est $1.47

+5.4%

Revenue

$784M

Est $769M

+1.9%

Q4 2025

Nov 6, 2025

EPS

$1.24

Est $1.14

+8.8%

Revenue

$706M

Est $678M

+4.1%

Q3 2025

Aug 7, 2025

EPS

$1.17

Est $0.92

+27.2%

Revenue

$649M

Est $614M

+5.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 6, 2026	$1.42vs $1.19+19.3%	$762Mvs $730M+4.4%
Q1 2026	Feb 18, 2026	$1.55vs $1.47+5.4%	$784Mvs $769M+1.9%
Q4 2025	Nov 6, 2025	$1.24vs $1.14+8.8%	$706Mvs $678M+4.1%
Q3 2025	Aug 7, 2025	$1.17vs $0.92+27.2%	$649Mvs $614M+5.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
DXCMDexCom, Inc.Direct Competitor	23.29B	60.36	28.88	15.6%	19.31%	33.83%	0.51
TNDMTandem Diabetes Care, Inc.Direct Competitor	1.24B	18.03	-5.93	7.93%	-20.17%	-141.98%	2.86
NVCRNovoCure LimitedDirect Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
ITGRInteger Holdings CorporationDirect Competitor	2.97B	86.29	29.86	7.57%	7.67%	8.23%	0.80
ABTAbbott LaboratoriesProduct Competitor	149.97B	86.25	11.29	4.59%	31.88%	27.26%	0.32
MDTMedtronic plcProduct Competitor	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59
BDXBecton, Dickinson and CompanyProduct Competitor	52.45B	144.76	24.83	8.23%	8.01%	6.93%	0.76
NVONovo Nordisk A/SSupply Chain	203.36B	45.76	12.65	6.43%	33.14%	61.1%	0.67

Compare PODD vs Peers

Insulet Corporation (PODD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXCM

Most directly comparable listed peer for PODD.

Scale Benchmark

vs LLY

Larger-name benchmark to compare PODD against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXCM, TNDM, NVCR, ITGR

PODD Income Statement

Insulet Corporation (PODD) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	463.77M	563.82M	738.2M	904.4M	1.1B	1.31B	1.7B	2.07B	2.71B	2.9B
Revenue Growth %	26.37%	21.57%	30.93%	22.51%	21.49%	18.79%	30.02%	22.07%	30.73%	31.93%
Cost of Goods Sold	186.6M	193.66M	257.9M	322.1M	346.7M	499.7M	537.2M	625.9M	768.2M	840.9M
COGS % of Revenue	40.24%	34.35%	34.94%	35.61%	31.55%	38.28%	31.65%	30.21%	28.37%	-
Gross Profit	277.17M▲ 0%	370.17M▲ 33.6%	480.3M▲ 29.8%	582.3M▲ 21.2%	752.1M▲ 29.2%	805.6M▲ 7.1%	1.16B▲ 44.0%	1.45B▲ 24.6%	1.94B▲ 34.2%	2.06B▲ 0%
Gross Margin %	59.76%	65.65%	65.06%	64.39%	68.45%	61.72%	68.35%	69.79%	71.63%	71.01%
Gross Profit Growth %	31.31%	33.55%	29.75%	21.24%	29.16%	7.11%	43.98%	24.64%	34.18%	-
Operating Expenses	284.6M	342.8M	430.3M	530.8M	626.1M	768M	939.9M	1.14B	1.47B	1.55B
OpEx % of Revenue	61.37%	60.8%	58.29%	58.69%	56.98%	58.84%	55.38%	54.88%	54.14%	-
Selling, General & Admin	208.9M	248M	298M	384M	466M	587.8M	734.9M	917.2M	1.17B	1.22B
SG&A % of Revenue	45.04%	43.99%	40.37%	42.46%	42.41%	45.03%	43.3%	44.27%	43.02%	-
Research & Development	74.45M	88.61M	132.3M	146.8M	160.1M	180.2M	205M	219.6M	301.1M	331.2M
R&D % of Revenue	16.05%	15.72%	17.92%	16.23%	14.57%	13.81%	12.08%	10.6%	11.12%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income	-7.4M▲ 0%	27.4M▲ 470.3%	50M▲ 82.5%	51.5M▲ 3.0%	126M▲ 144.7%	37.6M▼ 70.2%	220M▲ 485.1%	308.9M▲ 40.4%	473.8M▲ 53.4%	507.2M▲ 0%
Operating Margin %	-1.6%	4.86%	6.77%	5.69%	11.47%	2.88%	12.96%	14.91%	17.5%	17.48%
Operating Income Growth %	30.87%	470.27%	82.48%	3%	144.66%	-70.16%	485.11%	40.41%	53.38%	-
EBITDA	6.5M	43M	77.9M	106.9M	183.4M	100.8M	292.8M	389.7M	586.9M	582.1M
EBITDA Margin %	1.4%	7.63%	10.55%	11.82%	16.69%	7.72%	17.25%	18.81%	21.67%	20.07%
EBITDA Growth %	107.73%	561.54%	81.16%	37.23%	71.56%	-45.04%	190.48%	33.09%	50.6%	37.16%
D&A (Non-Cash Add-back)	13.9M	15.6M	27.9M	55.4M	57.4M	63.2M	72.8M	80.8M	113.1M	74.9M
EBIT	-7.5M	31.5M	46.3M	54.9M	82.2M	45.8M	250.8M	342.9M	473.8M	332.7M
Net Interest Income	-18.6M	-21.3M	-34.6M	-45.1M	-61.2M	-26.7M	-7.6M	-3.2M	-45M	-30.4M
Interest Income	2.63M	6.71M	0	3M	500K	9.3M	28.6M	39.5M	34.7M	24.4M
Interest Expense	19.19M	22.2M	34.6M	48.1M	61.7M	36M	36.2M	42.7M	79.7M	45M
Other Income/Expense	-19.2M	-22.2M	-35.5M	-41.8M	-105.5M	-27.8M	-5.4M	-8.7M	-134.3M	-102.8M
Pretax Income	-26.6M▲ 0%	5.2M▲ 119.5%	14.5M▲ 178.8%	9.7M▼ 33.1%	20.5M▲ 111.3%	9.8M▼ 52.2%	214.6M▲ 2089.8%	300.2M▲ 39.9%	339.5M▲ 13.1%	404.4M▲ 0%
Pretax Margin %	-5.74%	0.92%	1.96%	1.07%	1.87%	0.75%	12.65%	14.49%	12.54%	13.94%
Income Tax	200K	1.9M	2.9M	2.9M	3.7M	5.2M	8.3M	-118.1M	92.4M	57.7M
Effective Tax Rate %	-0.75%	36.54%	20%	29.9%	18.05%	53.06%	3.87%	-39.34%	27.22%	14.27%
Net Income	-26.83M▲ 0%	3.29M▲ 112.3%	11.6M▲ 252.4%	6.8M▼ 41.4%	16.8M▲ 147.1%	4.6M▼ 72.6%	206.3M▲ 4384.8%	418.3M▲ 102.8%	247.1M▼ 40.9%	302.8M▲ 0%
Net Margin %	-5.79%	0.58%	1.57%	0.75%	1.53%	0.35%	12.16%	20.19%	9.12%	10.44%
Net Income Growth %	7.09%	112.27%	252.37%	-41.38%	147.06%	-72.62%	4384.78%	102.76%	-40.93%	-24.71%
Net Income (Continuing)	-26.8M	3.3M	11.6M	6.8M	16.8M	4.6M	206.3M	418.3M	247.1M	302.8M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.46▲ 0%	0.05▲ 111.7%	0.19▲ 251.9%	0.10▼ 47.4%	0.25▲ 150.0%	0.07▼ 73.7%	2.94▲ 4368.1%	5.78▲ 96.6%	3.48▼ 39.8%	4.31▲ 0%
EPS Growth %	8%	111.74%	251.85%	-47.37%	150%	-73.68%	4368.09%	96.6%	-39.79%	-22.66%
EPS (Basic)	-0.46	0.06	0.19	0.11	0.25	0.07	2.96	5.97	3.51	-
Diluted Shares Outstanding	58M	61.01M	62.3M	65.95M	68.58M	69.91M	73.63M	73.89M	71.89M	70.2M
Basic Shares Outstanding	58M	58.86M	60.59M	64.73M	67.7M	69.38M	69.75M	70.08M	70.35M	69.99M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

PODD Balance Sheet

Insulet Corporation (PODD) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	537.17M	454.01M	581.5M	1.24B	1.32B	1.3B	1.57B	1.87B	1.89B	1.71B
Cash & Short-Term Investments	440.06M	288.95M	376.1M	947.6M	791.6M	674.7M	704.2M	953.4M	716.1M	480.4M
Cash Only	272.58M	113.91M	203.7M	907.2M	791.6M	623.9M	650.7M	953.4M	716.1M	480.4M
Short-Term Investments	167.48M	175.04M	172.4M	40.4M	0	50.8M	53.5M	0	0	0
Accounts Receivable	53.37M	76.67M	82.8M	83.8M	161M	205.6M	359.7M	365.5M	516.9M	544.7M
Days Sales Outstanding	42.01	49.63	40.94	33.82	53.48	57.49	77.36	64.4	69.67	61.91
Inventory	33.79M	71.41M	101M	154.3M	303.2M	346.8M	402.6M	430.4M	452.6M	462.5M
Days Inventory Outstanding	66.1	134.6	142.94	174.85	319.2	253.32	273.55	250.99	215.05	196.23
Other Current Assets	9.95M	16.98M	21.6M	52M	60.7M	71.7M	99.8M	121.9M	203.1M	221.9M
Total Non-Current Assets	279.57M	474.74M	561.4M	635.2M	732.3M	952.3M	1.02B	1.22B	1.3B	1.28B
Property, Plant & Equipment	107.86M	258.38M	415.5M	493.6M	546.4M	625.9M	692.8M	759.8M	863.2M	830.4M
Fixed Asset Turnover	4.30x	2.18x	1.78x	1.83x	2.01x	2.09x	2.45x	2.73x	3.14x	3.70x
Goodwill	39.84M	39.65M	39.8M	39.8M	39.8M	51.7M	51.7M	51.5M	51.6M	51.6M
Intangible Assets	4.35M	10.38M	13.2M	28.7M	36.6M	75.5M	98.7M	98.5M	117.1M	115.2M
Long-Term Investments	125.55M	140.78M	58.4M	14.8M	19.3M	15M	0	5.5M	20.1M	58.3M
Other Non-Current Assets	1.97M	25.54M	34.5M	58.3M	90.2M	184.2M	178.7M	159.4M	167.3M	935.6M
Total Assets	816.74M▲ 0%	928.74M▲ 13.7%	1.14B▲ 23.1%	1.87B▲ 63.9%	2.05B▲ 9.4%	2.25B▲ 9.9%	2.59B▲ 15.0%	3.09B▲ 19.3%	3.19B▲ 3.3%	2.99B▲ 0%
Asset Turnover	0.57x	0.61x	0.65x	0.48x	0.54x	0.58x	0.66x	0.67x	0.85x	0.92x
Asset Growth %	78.86%	13.71%	23.06%	63.87%	9.39%	9.87%	14.97%	19.3%	3.33%	8.78%
Total Current Liabilities	86.03M	115.66M	157.7M	207.8M	228.8M	364.7M	451.2M	528.4M	680.1M	687.5M
Accounts Payable	24.41M	25.5M	54.5M	54.1M	37.7M	30.8M	19.2M	19.8M	75M	149.8M
Days Payables Outstanding	47.75	48.06	77.13	61.31	39.69	22.5	13.05	11.55	35.64	40.05
Short-Term Debt	0	0	3.6M	20.5M	30.1M	31.1M	52.9M	85.9M	22.2M	18.6M
Deferred Revenue (Current)	2.36M	1.18M	3.2M	5.4M	3.5M	16.1M	15.4M	12M	14M	47.9M
Other Current Liabilities	24.31M	51.15M	50.6M	74.7M	87.2M	190.8M	241.7M	267.9M	359.7M	668.9M
Current Ratio	6.24x	3.93x	3.69x	5.96x	5.75x	3.56x	3.47x	3.54x	2.78x	2.78x
Quick Ratio	5.85x	3.31x	3.05x	5.21x	4.43x	2.61x	2.58x	2.73x	2.11x	2.11x
Cash Conversion Cycle	60.35	136.17	106.75	147.37	333	288.31	337.86	303.84	249.08	218.09
Total Non-Current Liabilities	572.2M	600.99M	909.3M	1.06B	1.26B	1.41B	1.4B	1.35B	995.1M	997.1M
Long-Term Debt	566.17M	591.98M	887.9M	1.04B	1.25B	1.37B	1.37B	1.3B	979.7M	0
Capital Lease Obligations	0	0	14.4M	12M	7.6M	27.4M	29.5M	40M	48.9M	48.9M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	5.13M	8.11M	6M	4.8M	5.8M	6.7M	6.5M	9.6M	-35M	1.08B
Total Liabilities	658.23M	716.64M	1.07B	1.27B	1.49B	1.77B	1.86B	1.88B	1.68B	1.68B
Total Debt	566.17M	591.98M	905.9M	1.08B	1.29B	1.43B	1.45B	1.42B	1.05B	18.6M
Net Debt	293.6M	478.07M	702.2M	169M	494.9M	808.9M	798.1M	468.6M	334.7M	-461.8M
Debt / Equity	3.57x	2.79x	11.94x	1.78x	2.31x	3.01x	1.98x	1.17x	0.69x	0.69x
Debt / EBITDA	87.10x	13.77x	11.63x	10.07x	7.01x	14.21x	4.95x	3.65x	1.79x	0.03x
Net Debt / EBITDA	45.17x	11.12x	9.01x	1.58x	2.70x	8.02x	2.73x	1.20x	0.57x	0.57x
Interest Coverage	-0.39x	1.42x	1.34x	1.14x	1.33x	1.27x	6.93x	8.03x	5.94x	7.39x
Total Equity	158.52M▲ 0%	212.1M▲ 33.8%	75.9M▼ 64.2%	603.6M▲ 695.3%	556.3M▼ 7.8%	476.4M▼ 14.4%	732.7M▲ 53.8%	1.21B▲ 65.4%	1.52B▲ 25.1%	1.3B▲ 0%
Equity Growth %	151.02%	33.8%	-64.21%	695.26%	-7.84%	-14.36%	53.8%	65.36%	25.06%	93.27%
Book Value per Share	2.73	3.48	1.22	9.15	8.11	6.81	9.95	16.40	21.08	18.56
Total Shareholders' Equity	158.52M	212.1M	75.9M	603.6M	556.3M	476.4M	732.7M	1.21B	1.52B	1.3B
Common Stock	58K	59K	100K	100K	100K	100K	100K	100K	100K	100K
Retained Earnings	-707.25M	-683.61M	-672M	-666.3M	-649.5M	-584.3M	-378M	40.3M	287.4M	0
Treasury Stock	0	0	0	0	0	0	0	0	-60.4M	0
Accumulated OCI	-493K	-2.9M	-1.2M	5.5M	-2.2M	20M	8M	-13.2M	13.2M	5.6M
Minority Interest	0	0	0	0	0	0	0	0	0	0

PODD Cash Flow Statement

Insulet Corporation (PODD) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	41.3M	35.9M	98.4M	84M	-68.1M	119M	145.7M	430.3M	569.3M	569.3M
Operating CF Margin %	8.91%	6.37%	13.33%	9.29%	-6.2%	9.12%	8.59%	20.77%	21.02%	-
Operating CF Growth %	159.57%	-13.08%	174.09%	-14.63%	-181.07%	274.74%	22.44%	195.33%	32.3%	256.47%
Net Income	-26.8M	3.3M	11.6M	6.8M	16.8M	4.6M	206.3M	418.3M	247.1M	302.8M
Depreciation & Amortization	13.9M	15.6M	27.9M	55.4M	57.4M	63.2M	72.8M	80.8M	90.4M	101.1M
Stock-Based Compensation	31.9M	37.5M	28.7M	35.9M	34.4M	40.9M	48.3M	69.3M	62.7M	45.5M
Deferred Taxes	0	0	0	0	0	-1M	500K	-136.9M	62.2M	69.2M
Other Non-Cash Items	20.6M	32.3M	49.9M	49.3M	86.9M	13.8M	8.4M	15.8M	130M	66.2M
Working Capital Changes	1.7M	-52.8M	-19.7M	-63.4M	-263.6M	-2.5M	-190.6M	-17M	-23.1M	34.5M
Change in Receivables	-26.3M	-14.6M	-10.9M	-13.7M	-71.3M	-51.8M	-154.2M	-10.4M	-140.2M	-94.7M
Change in Inventory	1.7M	-38.8M	-30.2M	-50.5M	-154.4M	-49.1M	-53.6M	-32.4M	-10.6M	-38M
Change in Payables	27.3M	-5.4M	25.6M	7.1M	-15.6M	-2.4M	-11M	2.2M	49.2M	84.1M
Cash from Investing	-210.8M	-184.5M	-73.6M	14M	-82.7M	-191.1M	-119.4M	-146.2M	-222.7M	-234.7M
Capital Expenditures	-77.23M	-162.35M	0	-166.5M	-122.7M	-157.3M	-109.2M	-134M	-191.6M	-214.5M
CapEx % of Revenue	16.65%	28.8%	23.15%	18.41%	11.17%	12.05%	6.43%	6.47%	7.08%	-
Acquisitions	0	0	0	0	0	-26M	-3M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	26K	-46K	-170.9M	0	0	0	0	0	-31.1M	-20.2M
Cash from Financing	304.5M	-8.7M	73.5M	605.5M	40.7M	-40.3M	-13.6M	-28.1M	-595.3M	-1.19B
Debt Issued (Net)	292.8M	-6.7M	116.6M	126.6M	49.4M	-39.8M	-27M	-40.6M	-708.1M	-981.5M
Equity Issued (Net)	15.8M	15.81M	-34.5M	509.2M	23.5M	16.3M	26.9M	20.1M	-25.7M	-55.9M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	-59.6M	-359.6M
Other Financing	-4.1M	-17.82M	-8.6M	-30.3M	-32.2M	-16.8M	-13.5M	-7.6M	138.5M	-155.6M
Net Change in Cash	135.4M▲ 0%	-158.7M▼ 217.2%	99.8M▲ 162.9%	708.3M▲ 609.7%	-115.6M▼ 116.3%	-116.7M▼ 1.0%	14.5M▲ 112.4%	249.2M▲ 1618.6%	-237.3M▼ 195.2%	-802.7M▲ 0%
Free Cash Flow	-36.02M▲ 0%	-126.45M▼ 251.1%	-72.5M▲ 42.7%	-82.5M▼ 13.8%	-190.8M▼ 131.3%	-38.3M▲ 79.9%	70.1M▲ 283.0%	305.4M▲ 335.7%	377.7M▲ 23.7%	415.7M▲ 0%
FCF Margin %	-7.77%	-22.43%	-9.82%	-9.12%	-17.36%	-2.93%	4.13%	14.74%	13.95%	14.33%
FCF Growth %	-480.58%	-251.08%	42.67%	-13.79%	-131.27%	79.93%	283.03%	335.66%	23.67%	48.84%
FCF per Share	-0.62	-2.07	-1.16	-1.25	-2.78	-0.55	0.95	4.13	5.25	5.25
FCF Conversion (FCF/Net Income)	-1.54x	10.91x	8.48x	12.35x	-4.05x	25.87x	0.71x	1.03x	2.30x	1.37x
Interest Paid	2.5M	0	0	2.6M	21.5M	34.2M	49.9M	0	0	0
Taxes Paid	500K	800K	2.5M	3M	7M	5.5M	8.1M	0	0	0

PODD Key Ratios

Insulet Corporation (PODD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-24.21%	1.78%	8.06%	2%	2.9%	0.89%	34.12%	43.03%	18.12%	21.38%
Return on Invested Capital (ROIC)	-1.56%	3.6%	5.11%	4.98%	10.36%	2.41%	11.72%	14.43%	20.13%	20.13%
Gross Margin	59.76%	65.65%	65.06%	64.39%	68.45%	61.72%	68.35%	69.79%	71.63%	71.01%
Net Margin	-5.79%	0.58%	1.57%	0.75%	1.53%	0.35%	12.16%	20.19%	9.12%	10.44%
Debt / Equity	3.57x	2.79x	11.94x	1.78x	2.31x	3.01x	1.98x	1.17x	0.69x	0.69x
Interest Coverage	-0.39x	1.42x	1.34x	1.14x	1.33x	1.27x	6.93x	8.03x	5.94x	7.39x
FCF Conversion	-1.54x	10.91x	8.48x	12.35x	-4.05x	25.87x	0.71x	1.03x	2.30x	1.37x
Revenue Growth	26.37%	21.57%	30.93%	22.51%	21.49%	18.79%	30.02%	22.07%	30.73%	31.93%

PODD SEC Filings & Documents

Insulet Corporation (PODD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 6, 2026·SEC

Material company update

Apr 29, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

FY 2026

Feb 18, 2026·SEC

FY 2025

Feb 21, 2025·SEC

FY 2024

Feb 23, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 6, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

PODD Frequently Asked Questions

Insulet Corporation (PODD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Insulet Corporation (PODD) reported $2.90B in revenue for fiscal year 2025.

Insulet Corporation (PODD) grew revenue by 30.7% over the past year. This is strong growth.

Yes, Insulet Corporation (PODD) is profitable, generating $302.8M in net income for fiscal year 2025 (9.1% net margin).

Dividend & Returns

Insulet Corporation (PODD) has a return on equity (ROE) of 18.1%. This is reasonable for most industries.

Insulet Corporation (PODD) generated $415.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PODD

Insulet Corporation (PODD) financial analysis — history, returns, DCA and operating performance tools

Full PODD Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Insulet Corporation(PODD)Earnings, Financials & Key Ratios

PODD Key Insights

✓Strengths

✗Weaknesses

PODD Price & Volume

PODD Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

PODD Recent Earnings

PODD Peer Comparison

Compare PODD vs Peers

vs DXCM

vs LLY

Compare Top 5

PODD Income Statement

PODD Balance Sheet

PODD Cash Flow Statement

PODD Key Ratios

PODD SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

PODD Frequently Asked Questions

Explore More PODD

Full PODD Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation